Center of Excellence in Vaccine Research and Development,
Chulalongkorn University (Chula VRC)
Chula VRC was formally established in 2017 under the supervision of Professor Kiat Ruxrungtham. We consists of faculty staff and researchers with common interest in vaccine research and development to work together and share their knowledge and experience leading to the strength of the team. We focuses not only on vaccines against infectious diseases, such as HIV infection, dengue fever, leptospirosis, and emerging infections including novel corona virus disease (COVID-19) but also vaccines against non-infectious diseases including house dust mite allergy.
Key Contact Persons
Latest News & Events
The mRNA Technology Transfer Programme organized on 18 March 2024 in Singapore the 4th Sc
From https://www.who.int/news-room/events/detail/2023/10/31/default-calendar/who-mpp-regi
From: Department of Chemical and Biological Engineering, University of Sheffield Professo
Congratulations to Drew Weissman and Katalin Kariko for the Nobel Prize in Physiology or
From: The Independent Panel for Pandemic Preparedness and Response Statement of the Right
From BioNet-Asia ChulaCov19 BNA159 is a COVID–19 mRNA vaccine developed by Chulalong
